多层图表注意力神经网络,用于准确地绘制药物向相互作用的地图
Qianwen Lu1, Zhiheng Zhou2,3, Qi Wang4
1SDU-ANU Joint Science College, Shandong University, Weihai, 264209, Shandong, China.
Scientific reports
|October 31, 2024
概括
这项研究引入了一种新的多层图表注意力神经网络 (MLGANN),用于预测药物向相互作用 (DTI). 通过整合多源数据和网络信息,MLGANN提高了预测准确度,优于现有的方法.
科学领域:
- 计算机化药物发现.
- 生物信息学是一种生物信息学.
- 在药理学中的机器学习.
背景情况:
- 对药物向相互作用 (DTI) 的准确预测对于药物发现和重新定位至关重要.
- 现有的计算方法往往难以充分利用多源信息和网络复杂性.
研究的目的:
- 引入一个新的计算框架,多层图表注意力神经网络 (MLGANN),用于增强DTI预测.
- 提高药物与生物点之间的相互作用预测的准确性和效率.
主要方法:
- 开发了MLGANN,一种多层网络方法,可以捕获直接和多层次的DTI信息.
- 集成图形卷积网络 (GCN) 具有自我注意机制,可处理多种数据源.
- 采用了突破性的计算框架,利用多个来源的信息.
主要成果:
- 在实验评估中,MLGANN与现有的DTI预测方法相比,表现优越.
- 该模型通过GCN和自我注意力有效地整合了异质数据源.
- 预测准确度和效率的显著改善被观察到.
结论:
- 该研究强调了多源数据和网络异质性在DTI预测中的重要性.
- MLGANN为推进制药研究和药物发现提供了一个强大的新工具.
- 这些发现为未来的药物开发策略提供了新的视角.
更多相关视频
相关概念视频
Protein Networks
3.9K
An organism can have thousands of different proteins, and these proteins must cooperate to ensure the health of an organism. Proteins bind to other proteins and form complexes to carry out their functions. Many proteins interact with multiple other proteins creating a complex network of protein interactions.
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
3.9K
Drug-Receptor Interaction: Antagonist
2.8K
An antagonist is a drug that binds strongly to a receptor without activating it. An antagonist prevents other molecules, such as neurotransmitters or hormones, from binding to the receptor and triggering a cellular response. Such interaction effectively hinders the normal physiological processes mediated by the receptor, resulting in various pharmacological effects depending on the specific receptor targeted.
Antagonists can be classified as competitive or noncompetitive based on their...
Antagonists can be classified as competitive or noncompetitive based on their...
2.8K
Protein-protein Interfaces
12.5K
Many proteins form complexes to carry out their functions, making protein-protein interactions (PPIs) essential for an organism's survival. Most PPIs are stabilized by numerous weak noncovalent chemical forces. The physical shape of the interfaces determines the way two proteins interact. Many globular proteins have closely-matching shapes on their surfaces, which form a large number of weak bonds. Additionally, many PPIs occur between two helices or between a surface cleft and a...
12.5K
Targets for Drug Action: Overview
6.1K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
6.1K
Drug-Receptor Interaction: Agonist
2.4K
Agonists are drugs that interact with specific receptors in the body to produce a biological response. When an agonist binds to a receptor, it activates or enhances the receptor's function, leading to physiological effects. The interaction between agonist drugs and receptors is crucial for their therapeutic action in various medical treatments.
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous...
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous...
2.4K
Drug-Receptor Interactions
5.0K
Drug-receptor interaction describes the binding of receptors by drugs, but not all drug-receptor interactions result in activation and tissue response. For instance, the binding of agonists activates the receptor to generate a cellular reaction, while antagonists bind to receptors without causing their activation.
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue....
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue....
5.0K


